论文部分内容阅读
Background: As a kind of promising anti-tumor immunotherapy, autologous dendritic cell (DC) vaccine derived from peripheral blood monocytes faced limitations including deficiency of function and shortage of cell number.CD34+ progenitors are another ideal source of DC generation and different methods were explored and resulted in different cell number, various function of DC.